Publications by authors named "Todd Durell"

Claim this Profile
A
Atomoxetine effects on executive function as measured by the BRIEF--a in young adults with ADHD: a randomized, double-blind, placebo-controlled study.
Lenard A Adler, David B Clemow, David W Williams, Todd M Durell

PLoS One· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot project.
Andrew F Leuchter, James J McGough, Alexander S Korb, Aimee M Hunter, Paul E A Glaser, Todd M Durell

J Psychiatr Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder.
Himanshu P Upadhyaya, Durisala Desaiah, Kory J Schuh, Frank P Bymaster, Mary J Kallman, Todd M Durell

Psychopharmacology (Berl)· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial.
Todd M Durell, Lenard A Adler, Dave W Williams, Ahmed Deldar, James J McGough

J Clin Psychopharmacol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atomoxetine treatment outcomes in adolescents and young adults with attention-deficit/hyperactivity disorder: results from a post hoc, pooled analysis.
Lenard A Adler, Timothy Wilens, Shuyu Zhang, Ralf W Dittmann, Deborah N D'Souza, Todd M Durell

Clin Ther· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between African-American or Caucasian origin and outcomes in the olanzapine treatment of acute mania: a pooled analysis of three adult studies conducted in the United States of America.
Elisabeth K Degenhardt, Jorge M Tamayo, Hassan H Jamal, Jennifer Gatz, Mauricio Tohen, Todd M Durell

Int Clin Psychopharmacol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stimulant formulation and motivation for nonmedical use of prescription attention-deficit/hyperactivity disorder medications in a college-aged population.
Himanshu P Upadhyaya, Larry A Kroutil, Deborah Deas, Todd M Durell, David L Van Brunt

Am J Addict· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of race on efficacy and safety during treatment with olanzapine in schizophrenia, schizophreniform or schizoaffective disorder.
Virginia L Stauffer, Jennifer L Sniadecki, Kevin W Piezer, Jennifer Gatz, Sara Kollack-Walker, Todd Durell

BMC Psychiatry· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies.
Mauricio Tohen, Michael Case, Madhukar H Trivedi, Michael E Thase, Scott J Burke, Todd M Durell

J Clin Psychiatry· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atomoxetine treatment for ADHD: younger adults compared with older adults.
Todd Durell, Lenard Adler, Timothy Wilens, Martin Paczkowski, Kory Schuh

J Atten Disord· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective safety analysis of atomoxetine in adult ADHD patients with or without comorbid alcohol abuse and dependence.
Lenard Adler, Timothy Wilens, Shuyu Zhang, Todd Durell, Daniel Walker

Am J Addict· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder.
Lenard A Adler, Michael Liebowitz, William Kronenberger, Meihua Qiao, Richard Rubin, Todd Durell

Depress Anxiety· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of open-label atomoxetine on African-American and Caucasian pediatric outpatients with attention-deficit/hyperactivity disorder.
Todd M Durell, Andres J Pumariega, Eugenio M Rothe, Jorge M Tamayo, David Baron

Ann Clin Psychiatry· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of nonmedical methamphetamine use in the United States.
Todd M Durell, Larry A Kroutil, Paul Crits-Christoph, Nina Barchha, David L Van Brunt

Subst Abuse Treat Prev Policy· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latino versus Caucasian response to atomoxetine in attention-deficit/hyperactivity disorder.
Jorge M Tamayo, Andres Pumariega, Eugenio M Rothe, Douglas Kelsey, Albert J Allen, Todd M Durell

J Child Adolesc Psychopharmacol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans.
Joshua A Lile, William W Stoops, Todd M Durell, Paul E A Glaser, Craig R Rush

Exp Clin Psychopharmacol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis